Impact Factor 2025

Search

Search Results

##search.searchResults.foundPlural##

Emergency management of patients being treated with oral anticoagulants

Franco Manzato, Massimo Franchini

234-241

17-12-2013

https://doi.org/10.4081/itjm.2013.234

1260

PDF: 983

HTML: 321
Stroke prevention in atrial fibrillation: findings from Tuscan FADOI Stroke Registry

Luca Masotti, Rinaldo Innocenti, Stefano Spolveri, Irene Chiti, Grazia Panigada, Cristiana Seravalle, Giancarlo Landini, Alberto Fortini, Rino Migliacci, Raffaele Laureano, for Tuscan FADOI Stroke Registry Investigators

134-140

12-06-2014

https://doi.org/10.4081/itjm.2014.450

1849

PDF: 1413

Appendix: 642

HTML: 635
Characteristics and clinical management of acute pulmonary embolism in real world: findings from TUSCAN-PE study

Luca Masotti, Filippo Pieralli, Grazia Panigada, Francesco Corradi, Rino Migliacci, Salvatore Lenti, Alessandro Tafi, Carlo Nozzoli, Giancarlo Landini, for TUSCAN-PE Investigators

125-133

03-06-2014

https://doi.org/10.4081/itjm.2014.504

2353

PDF: 1518

Appendix: 1162

HTML: 773
Proton pump inhibitors overuse: only inappropriate prescriptions or further iatrogenic damage?

Mario Visconti

217-228

22-09-2015

https://doi.org/10.4081/itjm.2015.562

2966

PDF: 1305

HTML: 2250
The incidence of bleeding in patients with nonvalvular atrial fibrillation using anticoagulants: a real-world report with the biggest Vietnamese data

Bui The Dung, Cao Ngoc Mai Han, Tran Hoa, Nguyen Thanh Hien

17-02-2025

https://doi.org/10.4081/itjm.2025.1807

2407

PDF: 569

HTML: 1
Old and new oral anticoagulants for secondary stroke prevention in atrial fibrillation

Tommaso Sacquegna, Anna Zaniboni, Andrea Rubboli, Gaetano Procaccianti, Michela Crisci, Fabiola Maioli, Giorgia Arnone, Giuseppe Di Pasquale

314-322

15-12-2015

https://doi.org/10.4081/itjm.2015.468

2154

PDF: 1065

HTML: 1296
Direct oral anticoagulants in real practice: which doses for which patients. Limitations and bleeding risk compared to vitamin K antagonists

Giancarlo Landini, Luca Masotti

41-47

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.41

1089

PDF: 953
The practical management of bleedings during treatment with direct oral anticoagulants: the emergency reversal therapy

Luca Masotti, Giancarlo Landini, Grazia Panigada

48-58

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.48

1618

PDF: 1123
Clinical case and short review of extreme short bowel syndrome: an update 21 years after

Pasquale Mansueto, Aurelio Seidita, Salvatore Iacono, Antonio Carroccio

45-51

22-03-2016

https://doi.org/10.4081/itjm.2016.543

2017

PDF: 1094

HTML: 1310
D-dimer: a useful tool in gauging optimal duration of oral anticoagulant therapy?

M. Silingardi, A. Pizzini, I. Iori

45-47

03-05-2013

https://doi.org/10.4081/itjm.2007.2.45

1222

PDF: 2532
Sex-gender and atrial fibrillation treatment in the AntiThrombotic Agents in Atrial Fibrillation (ATA-AF) study

Cecilia Politi, Tiziana Ciarambino, Letizia Riva, Stefania Frasson, Donata Lucci, Gualberto Gussoni, Lucio Gonzini, Mauro Campanini, Michele Gulizia, Giuseppe Di Pasquale, Giovanni Mathieu, on behalf of ATA-AF Steering Committee and Investigators

207-212

16-02-2016

https://doi.org/10.4081/itjm.2016.649

1997

PDF: 1589

Appendix: 784

HTML: 550
A review on management of antiphospholipid syndrome in clinical practice

Carmine Siniscalchi, Pietro Rossetti, Gaetano Carolla, Pierpaolo Di Micco, Adriano Stella, Michele Riva

13-09-2023

https://doi.org/10.4081/itjm.2023.1649

3404

PDF: 1365

HTML: 82
Pregnancy and heart disease: what Internists should know

Riccardo Gerloni, Domenico Panuccio

288-304

11-09-2017

https://doi.org/10.4081/itjm.2017.815

1687

PDF: 860

HTML: 285
The treatment of venous thromboembolism with new oral anticoagulants

Davide Imberti

29-35

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.29

1236

PDF: 982
Apixaban

Gianluca Airoldi, Mauro Campanini

128-134

07-03-2013

https://doi.org/10.4081/itjm.2011.128

1396

PDF: 2089
The FADOI (Federation of Associations of Hospital Doctors on Internal Medicine) position paper on cardiovascular prevention in the higher risk complex patients

Mauro Campanini, Giuliano Pinna, Roberto Nardi, on behalf of the FADOI Cardiovascular Prevention Position Statements Group

387-404

15-12-2015

https://doi.org/10.4081/itjm.2015.669

2494

PDF: 1052

Appendix: 525

HTML: 1474
Assessment and predictors of inappropriate dose of direct oral anticoagulants

Mosaad O. Almegren

09-01-2024

https://doi.org/10.4081/itjm.2024.1679

1313

pdf: 626

HTML: 173
Clinical characteristics of italian patients with venous thromboembolism enrolled in the RIETE Registry

Pierpaolo Di Micco, Alessandra Bura-Riviere, Renzo Poggio, Eros Tiraferri, Roberto Quintavalla, Adriana Visona, Paolo Prandoni, Maurizio Ciammaichella, Giovanni Barillari, RIETE Investigators

255-260

02-01-2012

https://doi.org/10.4081/itjm.2011.255

1224

PDF: 1285
Pharmacological interactions in novel oral anticoagulants, statins, and hypertension drugs in patients treated with direct-acting antivirals for hepatitis C: a Delphi Consensus project

Ivan Gentile, Giancarlo Agnelli, Angelo Avogaro, Claudio Borghi, Alessia Ciancio, Ernesto Claar, Patrizio Pasqualetti, Pasquale Perrone Filardi

25-11-2024

https://doi.org/10.4081/itjm.2024.1846

2407

PDF: 553

SUPPLEMENTARY MATERIAL: 318

ACKNOWLEDGMENTS: 274

HTML: 177
In-hospital gastric protection with proton pump inhibitors: adverse effects beyond (over)utilization?

Paolo Montanari

51-56

30-04-2013

https://doi.org/10.4081/itjm.2010.51

1032

PDF: 1328
New oral anticoagulants: key messages for clinicians

Matteo Giorgi-Pierfranceschi, Chiara Cattabiani, Francesco Dentali

74-84

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.74

1456

PDF: 1029
Doing more does not mean doing better: the FADOI contribution to the Slow Medicine program for a sustainable and wise healthcare system

Luigi Lusiani, Roberto Frediani, Roberto Nardi, Andrea Fontanella, Mauro Campanini

281-286

22-09-2015

https://doi.org/10.4081/itjm.2015.580

1873

PDF: 1033

Appendix: 669

HTML: 445
Segmental arterial mediolysis: a challenging diagnosis in internal medicine

Giulia Bombardieri, Alessandra Rustici, Michele Caselli, Chiara Chirico, Veronica Bocchi, Andrea Montagnani

27-09-2024

https://doi.org/10.4081/itjm.2024.1795

911

PDF: 428

HTML: 410
Too many dangerous allergies

Stefania Scarlini, Fabrizio Turrini, Antonella Caronna, Roberto Messora, Luca Sarti, Goretta Bonacorsi, Marco Bondi

51-55

25-10-2013

https://doi.org/10.4081/itjm.2013.390

2061

PDF: 1089

HTML: 371
Young FADOI and gender medicine: sex gender differences in cardiovascular disease

Tiziana Ciarambino, Miriam Gino, Paola Gnerre, Elena Barbagelata, Nunzia Barone, Francesca Saladini, Federica Lorenzi, Marta Zanon, Maria Cristina Pasquini, Cecilia Politi

23-31

20-03-2018

https://doi.org/10.4081/itjm.2018.864

3001

PDF: 1275

HTML: 504
Asymptomatic superior mesenteric vein thrombosis as unusual complication of acute cytomegalovirus infection: a case report

Michele Bertoni, Filippo Risaliti, Alessandra Giani, Emanuele Calabrese, Massimo Edoardo Di Natale

147-150

05-10-2015

https://doi.org/10.4081/itjm.2015.596

1783

PDF: 1018

HTML: 485
Screening of the key genes and signaling pathways for schizophrenia using bioinformatics and next generation sequencing data analysis

Iranna Kotturshetti, Basavaraj Vastrad, Veena Kori, Chanabasayya Vastrad, Shivakumar Kotrashetti

18-12-2024

https://doi.org/10.4081/itjm.2024.1830

3343

PDF: 716

SUPPLEMENTARY MATERIAL: 264

HTML: 15
Thrombophilias: therapeutic employment of direct oral anticoagulants in venous hypercoagulable states

Federico Cacciapuoti

136-142

17-09-2020

https://doi.org/10.4081/itjm.2020.1296

1074

PDF: 710

HTML: 361
Liver diseases and pregnancy

Pietro Crispino, Luca Fontanella, Paola Gnerre

278-287

11-09-2017

https://doi.org/10.4081/itjm.2017.817

1823

PDF: 1014

HTML: 337
Autoimmune liver diseases: internist's guide from bench to bedside

Mario Visconti

20-36

20-03-2015

https://doi.org/10.4081/itjm.2015.508

1972

PDF: 1280

HTML: 2296
Monitoring strategies for patients treated with the new oral anticoagulants and the need for laboratory evaluation of hemostasis

Andrea Fontanella, Pierpaolo Di Micco

59-64

24-12-2013

https://doi.org/10.4081/itjm.2013.s8.59

1109

PDF: 1049
Optimal duration of anticoagulant therapy in patients with venous thromboembolism

Gualtiero Palareti

235-244

14-09-2018

https://doi.org/10.4081/itjm.2018.1077

1761

PDF: 1960

HTML: 260
Effects of the availability of new oral anticoagulants in patients with non-valvular atrial fibrillation in the real world: the NAIF study

Francesco Ventrella, Franco Mastroianni, Sergio Cappello, Luigi Iamele, Samantha Errico, Massimo Errico

176-183

06-07-2016

https://doi.org/10.4081/itjm.2016.715

1690

PDF: 1071

HTML: 356

1 - 33 of 33 items

© PAGEPress 2008-2026 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185 • Privacy